EPHB3 and cancer: This regulatory mechanism, and its action as a specific inhibitor of HEK2, opens the possibility of further investigations regarding the role of this flavonoid molecule in cancer biology, and not only in the treatment of inflammatory and proliferative diseases, as previously supposed.